Analysts’ Upgrades for November, 8th (SONM, SSREY, STC, STIM, STL, SVRA, SWM, SYKE, TAL, TPTX)

Analysts’ upgrades for Friday, November 8th:

Sonim Technologies (NASDAQ:SONM) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Sonim Technologies Inc. provides ultra-rugged mobile phones and accessories. It provides its solutions under categories of ultra-rugged mobile phones based on the Android platform, which are capable of attaching to both public and private wireless networks; industrial-grade accessories and cloud-based software and application services. The company serves construction, energy and utility, hospitality, logistics, manufacturing, public sector and transportation sectors. Sonim Technologies Inc. is based in San Mateo, United States. “

SWISS RE LTD/S (OTCMKTS:SSREY) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Swiss Reinsurance Company Ltd operates as a reinsurance company. The Company offers automobile, liability, accident, engineering, marine, aviation, life, and health insurance. It provides wholesale reinsurance products, insurance-based capital market instruments, and supplementary risk management services to Property & Casualty and Life & Health clients and brokers around the globe. Swiss Reinsurance Company Ltd headquartered in Zurich, Switzerland. “

Stewart Information Services (NYSE:STC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $46.00 price target on the stock. According to Zacks, “Stewart Information Services Corporation’s primary business is title insurance. Stewart issues policies through issuing locations on homes and other real property located in all 50 states, the District of Columbia and several foreign countries. Stewart also sells computer-related services and information, as well as mapping products and geographic information systems, to domestic and foreign governments and private entities. “

Neuronetics (NASDAQ:STIM) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $5.75 price target on the stock. According to Zacks, “Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States. “

Sterling Bancorp (NYSE:STL) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Sterling Bancorp is the holding company for Sterling National Bank, a financial services firm. Sterling National Bank provides various banking and financial products and services primarily in New York, New Jersey, and Connecticut. It provides depository and cash management services and a broad portfolio of financing solutions-including working capital lines, accounts receivable and inventory financing, factoring, trade financing, payroll funding and processing, equipment financing, commercial and residential mortgages and mortgage warehouse lines of credit. Sterling Bancorp, formerly known as Provident New York Bancorp, is headquartered in New York. “

Savara (NASDAQ:SVRA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Savara Inc. is a clinical-stage pharmaceutical company. It focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Savara Inc., formerly known as Mast Therapeutics, Inc., is based in Austin, United States. “

Schweitzer-Mauduit International (NYSE:SWM) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $49.00 target price on the stock. According to Zacks, “Schweitzer-Mauduit International, Inc. (SWM) is a leading global provider of engineered solutions & advanced materials. From their origins as paper-making experts during the Renaissance to their cutting-edge technologies that solve today’s modern business challenges, SWM has consistently demonstrated a forward-looking approach to helping their customers succeed. In recent years, as they focused on expanding their reach beyond fiber-based materials, SWM established & grew its Advanced Materials & Structures platform to include expertise and capabilities in resin-based technologies and materials. As part of this effort, SWM acquired and integrated several global leaders specializing in market-leading netting & high-performance TPU films, including Argotec, Conwed Plastics and DelStar Technologies. SWM also acquired its subsidiary Filtrexx International, a global leader in the research & development of sustainable, compost-based solutions for erosion control and storm water management. “

Sykes Enterprises (NASDAQ:SYKE) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $42.00 price target on the stock. According to Zacks, “Sykes Enterprises, Incorporated is a global business process outsourcing (BPO) leader in providing comprehensive inbound customer engagement services to Global 2000 companies, primarily in the communications, financial services, healthcare, technology, transportation and retail industries. SYKES’ differentiated end-to-end service platform effectively engages consumers at every touch point in their customer lifecycle, starting from digital marketing and acquisition to customer support, technical support, up-sell/cross-sell and retention. SYKES provides its services through multiple communication channels encompassing phone, e-mail, web, chat, social media and digital self-service. Utilizing its integrated onshore/offshore and virtual at-home agent delivery models, SYKES serves its clients through two geographic operating segments: the Americas (United States, Canada, Latin America, India and the Asia Pacific region) and EMEA (Europe, Middle East and Africa). “

TAL Education Group (NYSE:TAL) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “TAL Education Group provides K-12 after-school tutoring service in China. It offers tutoring services to K-12 students covering academic subjects, including mathematics, English, Chinese, physics, chemistry and biology. The Company delivers its tutoring services through small classes, personalized premium services i.e. one-on-one tutoring and online course offerings. Its extensive network consists of learning centers and service centers in Beijing, Shanghai, Shenzhen, Guangzhou, Tianjin and Wuhan, as well as the Company’s online platform. TAL Education Group is headquartered in Beijing, the People’s Republic of China. “

Turning Point Therapeutics (NASDAQ:TPTX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $49.00 target price on the stock. According to Zacks, “Turning Point Therapeutics is a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients. Their internally developed and wholly owned pipeline of next-generation tyrosine kinase inhibitors (TKIs) targets numerous genetic drivers of cancer in both TKI-na├»ve and TKI-pretreated patients. The pervasive challenges of intrinsic and acquired treatment resistance often limit the response rate and durability of existing therapies. One of these challenges is the emergence of solvent front mutations, which are a common cause of acquired resistance to currently approved therapies for ROS1, TRK and ALK kinases. They have developed a macrocycle platform enabling us to design proprietary small, compact TKIs with rigid three-dimensional structures that potentially bind to their targets with greater precision and affinity than other kinase inhibitors. “

Tyme Technologies (NASDAQ:TYME) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $1.50 target price on the stock. According to Zacks, “Tyme Technologies, Inc. is a pharmaceutical company. The company is focused on creating medicines which specialize in the body’s immune system to treat diseases. Tyme Technologies, Inc. is headquartered in New York. “

United Insurance (NASDAQ:UIHC) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “United Insurance Holdings Corp., together with its subsidiaries, operates as a property and casualty insurance company. It primarily offers homeowners and dwelling fire insurance policies, as well as provides flood insurance through the National Flood Insurance Program. From its headquarters in St. Petersburg, United’s team of dedicated employees manages a completely integrated insurance company, including sales, underwriting, policyholder service and claims. It principally markets its products through insurance agents. “

Receive News & Ratings for Sonim Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonim Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply